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Epidemiologic studies of Chlamydia pneumoniae have been conducted throughout the world. A rate of antibody 
prevalence of approximately 50% has been found in adults, with small regional differences. We studied the antibody 
prevalence of C. pneumoniae in healthy persons and patients with acute respiratory infections in Japan. The microplate 
immunofluorescence antibody (MFA) technique was used for measuring antibodies, and the cases with IgG titers of 
2 1:64 were considered to have had past chlamydia1 exposure. Using this criterion, positive serum antibodies against 
C. pneumoniae,were found in 67.4% of healthy subjects and 74.2% of adult patients with respiratory infections. Some 
seroepidemiologic studies in Western countries have shown that epidemics of C. pneumoniae respiratory infections 
occur in a 4-6-year cycle, like a Mycoplasma pneumoniae infection. However, during our 7-year survey from 1988 to 
1994, we were not able to observe any epidemic episodes. The prevalence of the antibody was lower than 10% in children 
5 years old or younger. It increased rapidly between ages 6 and 15, reaching a plateau of 60%. 
Results suggest that in Japan a high infection rate might occur in children at nursery schools, kindergartens and 
elementary schools. We encountered an outbreak of C. pneumoniae infection and we were able to trace the source of 
the infection to a family and the spread of the infection to the schools which the children attended. Transmission is of 
the non-vector type. The incubation period is 3 to 4 weeks. Transmission occurs only after repeated and close contacts. 
Small outbreaks may occur in households and schools where persons have prolonged close contacts. Unlike acute viral 
infections, it may spread slowly. 
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EPIDEMIOLOGIC STUDIES 
Human pathogenic Chlamydia causes a variety of 
infections. C. trachomatis causes eye infection, sexually 
transmitted disease (STD) and respiratory tract in- 
fection. C. pneumoniae is now known to be one of the 
major pathogens in acute respiratory infections, and 
more recently the relationship between arteriosclerosis 
and C. pneumoniae has become one of the major areas 
of investigation in this field. 
Epidemiologic studies of C. pneumoniae and res- 
piratory diseases have been conducted throughout the 
world. A rate of antibody prevalence of approximately 
5040% has been found in adults worldwide, with s m a l l  
regional differences. In order to find the prevalence of 
chlamydial respiratory infection, especially that due to 
C. pneumoniae in Japan, we performed an antibody 
prevalence study in adults and children living in a 
district ofwestern Japan [l]. We used a MFA technique. 
IgG titers raised 2 64-fold were considered to be 
positive, indicating past exposure to chlamydial 
infection. Positive serum antibodies were found in 67% 
of the healthy adult controls and 74% of patients who 
had symptoms of acute respiratory infection. The rates 
for two other Chlamydia species were very low in 
comparison. 
Children below the age of 15 showed a relatively 
low positive rate of C. pneumoniae antibody. Prevalence 
of IgG antibodies was about 10% at age 5 or less, but 
it increased sharply between ages 6 and 15, reaching a 
plateau at 60%. From these results we estimated that in 
Japan a high rate of infection of C. pneumoniae might 
occur in children at nursery school, kindergarten and 
elementary schools. We also compared these antibody 
levels to C. pneumoniae by sex. IgA and IgM titers were 
signhcantly higher in males, especially in the patient 
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Some seroepidemiologic studies in Western coun- 
tries have shown that epidemics of C. pneumoniae 
infection occur in a 4-6-year cycle, like Mycoplasma 
pneumoniae infection. However, during our 7-year 
study we were not able to show any evidence of an 
epidemic. C. pneumoniae respiratory infection was 
considered to account for 12% of community-acquired 
pneumonia and bronchitis and 1-9% of upper 
respiratory tract infections. A low rate of involvement 
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of C. pneumoniae in acute exacerbations of chronic 
respiratory diseases has also been reported (5-9%). 
Some recent French data also support the importance 
of this organism as the most frequent causative 
organism of community-acquired pneumonia. 
STUDIES IN DISEASE TRANSMISSION IN JAPANESE 
CHILDREN 
We encountered outbreaks in two schools and families. 
We were able to trace the source of infection to a 
particular family and to follow the transmission of the 
infection to the schools [2]. 
The index case, a 28-year-old housewife, was seen 
at the hospital on 5 November with a complaint of 
a dry cough persisting for more than 1 month. C. 
pneumoniae infection was diagnosed by serology and 
polymerase chain reaction (PCR). Her husband and 
two daughters also had respiratory symptoms. C. pneu- 
moniae infection was shown in these family members by 
their high antibody titers. At the end of November they 
moved a distance of about 13 d e s  to stay with the 
index case's parents, with one more chance of contact 
on 27 November. The 6-year old nephew of the index 
case developed acute bronchtis and his grandparents 
also developed pharynsltis in late December. All of 
these three cases (the nephew, the father and the 
mother) had a problem involving C. pneumoniae 
infection. Based on this history of contacts, the 
incubation period of C. pneumoniae infection was 
estimated to be 3 to 4 weeks. They all responded well 
to macrolide therapy. 
At that time an increase in respiratory illness was 
noted in the two schools attended by the children of 
the two families. A SUNV of the two schools were 
conducted at the beginning of February. These were 
the nursery school, wluch the two daughters attended, 
and the kindergarten school of the nephew. A school 
kmdergarten was added to the  SUN^ as a control. The 
diagnostic tests on the children showed acute antibodies 
in 14% at the nursery school but only 7.7% at the 
kindergarten. However, considering the rate of antigen 
detection by area, isolation of Chlamydia was higher in 
the kindergarten. where the epidemic occurred a little 
later. 
Examining the serologic results in the family mem- 
bers, there were no positive results in the kindergarten, 
while 17% of family members in the nursery had acute 
antibodies. We considered that these discrepancies 
resulted ftom the two schools experiencing a relative 
time lag in the epidemic. 
Finally, in a survey of more than 200 children 
and their f d y  members, we could confiim 38 cases 
and some suspected cases of C. pneumoniae respiratory 
infection in this outbreak. Careful interviews with the 
patients made it clear that transmission was more likely 
to occur between good friends. The incubation period 
of C. pneumoniae was found to be 3 to 4 weeks. Close 
contact permitted airborne infection or person-to- 
person, non-vector spread. Infection may have occur- 
red in households and schools where a person had 
prolonged close contact. It spread slowly, taking 4 to 5 
months. 
CLINICAL FINDINGS IN ACUTE C. PNEUMONIA€ 
INFECTION 
The high incidence of pneumonia in elderly persons 
is one of the most important points distinguishmg 
C. pneumoniae dect ion tiom that due to Mycoplasma. 
The most common symptom of C. pneumoniae 
infection was prolonged dry cough, and some pneu- 
monic patients show a high fever, > 30 "C. However, 
these symptoms are also common in Mycoplasma 
infection. 
A country-wide multicenter clinical trial attempted 
to compare the action of roxithromycin to that of 
spdoxacin in primary respiratory infections [3]. Both 
of these agents have a very powerful antichlamydial 
activity and are commonly used for the treatment of 
respiratory infection in Japan. However, because of lack 
of methods for rapid diagnosis of Chlamydia, in almost 
all cases empirical treatment was initiated before the 
diagnosis was confirmed, and about 20% of the total 
cases were found to have chlamydial infections. 
C. pneumoniae was the most common cause of 
chlamyd~al respiratory infections, and clinical efficacy 
of roxithromycin was extremely high, at 92.9%, for all 
such infections. Furthermore, roxithromycin was also 
effective in non-chlamydial infection, at a rate of about 
80%. These figures suggest a high degree of usefLlness 
for this agent in acute respiratory infections. In another 
trial in orolaryngeal infection reported by Dr Baber, the 
clinical efficacy of roxithromycin against chlamydial 
infection was very high, at 84.6%. Sparfloxacin also 
showed a good clinical response rate. 
According to these data we can conclude that C. 
pneumoniae is one of the major pathogens in acute and 
chronic respiratory infections and we have to take it 
into account when c o h n t e d  by patients with 
respiratory symptoms. 
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